Clinical Trial Update: A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1, double-blind, two-period crossover study assessing pharmacokinetics, glucodynamics, and safety of BioChaperone Insulin Lispro versus Humalog (insulin l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BioChaperone Insulin Lispro (insulin lispro)
• Humalog (insulin lispro)

Snippet

Sponsor: Adocia | Conditions: Diabetes Mellitus Type 1 | Phase 1 | Status: COMPLETED